Navigation Links
Acute Ischemic Stroke Drug Market Will Remain Relatively Flat, Increasing From $360 Million in 2008 to $450 Million in 2018
Date:11/17/2009

WALTHAM, Mass., Nov. 17 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that sales of agents to treat acute ischemic stroke will remain relatively flat over the next decade, increasing from $360 million in 2008 to $450 million in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

The new Pharmacor report entitled Acute Ischemic Stroke finds that broadening the use of the recombinant tissue plasminogen activator (rt-PA; Genentech's Activase, other brands) and innovative therapies like stroke devices, such as Concentric Medical's Merci Retrieval System, will be important near-term advancements in the treatment of this indication. According to the report, drug-treatment rates for acute ischemic stroke will fluctuate modestly as the use of thrombolysis gradually increases, aided by continued improvements in stroke care throughout the major pharmaceutical markets.

Activase is now recommended for intravenous administration within 4.5 hours of stroke onset , as a result of recent positive clinical trial results from the third European Cooperative Acute Stroke Study (ECASS III). The report finds that the slowly expanding use of Activase will contribute to a modestly growing market through 2018, but a variety of limiting factors will continue to constrain the adoption of this and other time-sensitive treatments, and the promise of emerging therapies for acute ischemic stroke remains highly uncertain.

"In light of the recent discontinuations of several clinical-stage products, the stroke market continues to be a graveyard for drug development," said Decision Resources Analyst Jonathan Searles, B.A. "While drug developers continue to investigate novel therapies to expand the stroke armamentarium, interviewed experts express their lingering doubts about the clinical potential of late-stage compo
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
2. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
3. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
4. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
5. Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia
6. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
7. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
8. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
9. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
10. Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
11. Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... NEW YORK , Nov. 20, 2014  Market research ... as the "Year of The Buy, in the medical ... market for medical devices will produce just 3% growth ... competitive actions, including acquisitions of product lines and entrance ... an annual survey of medical devices, The Global ...
(Date:11/21/2014)...  The acceptance of two abstracts on the ... demonstrates continued interest in the Eclipse System, the ... of the abstracts, presented by Catherine Matthews ... Urogynecology and Reconstructive Pelvic Surgery at the University ... Written Abstract on Urogynecology/Pelvic Floor Disorders/Vaginal Surgery. ...
(Date:11/21/2014)... Nov. 20, 2014 Oxis International, Inc. (OXIS) (OXI.PA) ... election of Anthony J. Cataldo as Chief Executive ... Effective November 19, 2014, Ken Eaton resigned his ... of Directors of Oxis International, Inc. to pursue new opportunities. ... named Chief Executive Officer of Oxis International, Inc. Mr. Cataldo ...
Breaking Medicine Technology:Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3
... Feb. 18, 2011 Zimmer Holdings, Inc. (NYSE: ... announced it has received FDA clearance for the TM-S ... is the industry,s first cervical interbody device incorporating porous metal ... for cervical interbody fusion (IBF) in the United States. ...
... CARLSBAD, Calif., Feb. 18, 2011 Life Technologies Corporation ... Angel Carracedo and Dr. Mark Pallen as the winners of ... Grants Program.   (Logo:   http://photos.prnewswire.com/prnh/20110216/MM49339LOGO ) ... because of the ubiquitous nature of the Ion Torrent sequencing ...
Cached Medicine Technology:Zimmer Spine Introduces Industry's First Porous Metal Cervical Interbody Device 2Zimmer Spine Introduces Industry's First Porous Metal Cervical Interbody Device 3Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe 2Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe 3Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe 4Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe 5
(Date:11/22/2014)... (PRWEB) November 22, 2014 Hastings and ... decades of experience announces providing clients with the option ... firm offers clients a flexible, intuitive and easy to ... with having access to Google + allows clients to ... to make a more informed decision when retaining an ...
(Date:11/22/2014)... FL (PRWEB) November 22, 2014 ... Innovations are pleased to announce that Ashley Lombardo ... Thanksgiving #PayItForward contest. , Ms. Lombardo entered friend ... Kitchen Innovations. She wrote of how her friend is ... daughters as a single mom. Despite medical bills piling ...
(Date:11/22/2014)... Boulder, CO (PRWEB) November 22, 2014 ... on growth equity investments in the consumer brand ... LLC. The investment will be used to help ... new product pipeline rollout, particularly its proprietary apparel ... Suslow will join BackJoy’s Board of Directors. , ...
(Date:11/22/2014)... Aliso Viejo, California (PRWEB) November 22, 2014 ... have announced a new plugin entitled FCPX 3D Model bringing ... , “FCPX 3D Model allows users to add obj files ... of Pixel Film Studios. “Blurring the line between professional and ... FCPX3D Model from Pixel Film Studios allows Final Cut Pro ...
(Date:11/22/2014)... Wright & Schulte LLC reports that six ... been scheduled between October 2016 and April 2017 in ... District Judge Matthew F. Kennelly, who is overseeing the ... on November 6, 2014 that outlined the trial schedule ... and other activities in preparation for the bellwether jury ...
Breaking Medicine News(10 mins):Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 2Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 3Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 3Health News:Pixel Film Studios released FCPX 3D Model plugin Exclusively for Final Cut Pro X 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4
... Assam and Tripura have warned people against eating fish// ... saying the long time taken in transit rendered the ... ,The warning follows a report by the ... husks gets contaminated during the eight to 10 day ...
... Medical Journal report says that staff shortages in radiotherapy units ... and thus reducing their chances of surviving the condition. ... those in most developed countries and indeed many poorer countries," ... BMJ report. "Unfortunately the here and now of this is ...
... Ontario Government to launch a programme to ensure provision ... assault, who might have been exposed to the HIV/AIDS ... ($1,200) has resulted in a limited availability of this ... ,Very little effort is being done to promote ...
... the Health Minister of the Indian State of Bihar has announced ... introduced// in the state. An annual premium of Rs 250 will ... This will serve to provide the family with free health services ... the poverty line will receive the benefits without having to pay ...
... therapy is being provided to people who wish to give ... are over the age of 18 years// will benefit from ... Treatment for Ontario Patients (STOP) Study, which will also provide ... to which quitting method is more effective, according to Center ...
... transfer technology to generic drug manufacturers in the ... versions of the HIV drug saquinavir. ... Roche has announced further expansion of its current ... Developed Countries by providing local manufacturers with the ...
Cached Medicine News:Health News:Reach Of The Morning-After Pill Treatment Inadequate Among Sexual Assault Victims 2Health News:Roche offers HIV drug expertise to poor nations 2
Replacement bulb for Vibratome light system....
Injector blades come ten to an injector and allow for the easy replacement of Vibratome cutting blades....
Vibratome Specimen Adhesive is a special formulation developed by a major adhesive manufacturer for applications such as tissue mounting. The advantage of this adhesive is that it has a strong holdi...
... The Deluxe specimen bath mounts inside the ... bath allows for the separation of buffer and ... The bath can be sterilized and has round ... mounting specimens. The disks and bath surface ...
Medicine Products: